Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients’ Management

Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients’ Management

The estimation of anti-SARS-CoV-2 IgG antibodies is possibly the best approach to accurately establish the number of infected individuals and the seroprevalence of COVID-19 within a population. Thus, several commercial immunoassays have recently been developed. The purpose of our study was to assess...

Full description

Bibliographic Details
Main Authors: Matthaios Speletas, Maria A. Kyritsi, Alexandros Vontas, Aikaterini Theodoridou, Theofilos Chrysanthidis, Sophia Hatzianastasiou, Efthimia Petinaki, Christos Hadjichristodoulou
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Immunology
Subjects:
COVID-19
immunoassay
IgG
ELISA
chemiluminescent
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.609242/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.609242/full

Similar Items